Becton Dickinson

Roche leaves Abbott in the dust when it comes to US approval times
Roche leaves Abbott in the dust when it comes to US approval times
EP Vantage
devices
FDA
device approvals
Roche
Abbott Labs
Becton Dickinson
Flag link:
Appeals court overturns patent board in Bard spat with AngioDynamics
Appeals court overturns patent board in Bard spat with AngioDynamics
Mass Device
devices
CR Bard
Becton Dickinson
AngioDynamics
patents
Flag link:
Becton, Dickinson Sees Synergies From Bard With More to Come
Becton, Dickinson Sees Synergies From Bard With More to Come
Motley Fool
devices
earnings
Becton Dickinson
CR Bard
Flag link:
New Jersey jury hits BD subsidiary Bard with $33m pelvic mesh verdict
New Jersey jury hits BD subsidiary Bard with $33m pelvic mesh verdict
Mass Device
Becton Dickinson
C.R. Bard
pelvic mesh
Bard Avaulta vaginal sling
Align
New Jersey
Flag link:
Merit Medical to pay $100m for Bard, BD biopsy assets
Merit Medical to pay $100m for Bard, BD biopsy assets
Mass Device
Merit Medical
devices
CR Bard
Becton Dickinson
M&A
Flag link:
Becton, Dickinson beats The Street with Q4, 2017 numbers
Becton, Dickinson beats The Street with Q4, 2017 numbers
Mass Device
Becton Dickinson
earnings
devices
Flag link:
Becton Dickinson blood tubes under investigation in FDA probe of faulty lead tests
Becton Dickinson blood tubes under investigation in FDA probe of faulty lead tests
Mass Device
Becton Dickinson
devices
FDA
Magellan Diagnostics
Flag link:
Bard shareholders approve $24B merger with BD
Bard shareholders approve $24B merger with BD
Mass Device
CR Bard
Becton Dickinson
M&A
devices
Flag link:
Medtech M&A: The 10 biggest deals so far in 2017
Medtech M&A: The 10 biggest deals so far in 2017
Mass Device
devices
M&A
Abbott Labs
St. Jude Medical
Edwards Lifesciences
Valtech Cardio
Hologic
Cynosure
JNJ
Teleflex
Vascular Soltions
Cardinal Health
Medtronic
Becton Dickinson
CR Bard
Boston Scientific
Symetis
Integra LifeSciences
Codman Neuro
Stryker
Novadaq
Flag link:
Becton Dickinson to acquire Bard in $24B deal
Becton Dickinson to acquire Bard in $24B deal
Mass Device
Becton Dickinson
CR Bard
devices
M&A
Flag link:
Becton, Dickinson: Road Map Into The Future
Becton, Dickinson: Road Map Into The Future
Seeking Alpha
Becton Dickinson
Flag link:
Inside Becton Dickinson’s Biggest Growth Driver
Inside Becton Dickinson’s Biggest Growth Driver
Yahoo/Market Realist
Becton Dickinson
Flag link:
AbbVie, other pharma companies dominate list of 'most meaningful' places to work in US
AbbVie, other pharma companies dominate list of 'most meaningful' places to work in US
BioPharma Dive
AbbVie
Becton Dickinson
Celgene
Medtronic
Flag link:
Becton Dickinson's $12B CareFusion buyout set to close tomorrow
Becton Dickinson's $12B CareFusion buyout set to close tomorrow
Mass Device
Becton Dickinson
CareFusion
M&A
devices
Flag link:
Top 10 med tech market movers in 2014
Top 10 med tech market movers in 2014
Fierce Medical Devices
devices
EXACT Sciences
Edwards Lifesciences
Illumina
DexCom
Covidien
NuVasive
Intuitive Surgical
Steris
Sirona Dental Systems
Becton Dickinson
Flag link:
Becton, Dickinson to float debt to help fund CareFusion buy
Becton, Dickinson to float debt to help fund CareFusion buy
Seeking Alpha
Becton Dickinson
CareFusion
M&A
Diacoustic Medical Devices
Flag link:
Becton Dickinson to Buy CareFusion in Deal Valued at $12.2 Billion
Becton Dickinson to Buy CareFusion in Deal Valued at $12.2 Billion
TheStreet.com
Becton Dickinson
CareFusion
M&A
devices
Flag link:
BD: We'll make half our products in Asia by 2024
BD: We'll make half our products in Asia by 2024
Mass Device
Becton Dickinson
devices
Asia
Flag link:
Becton Dickinson buys Alverix for $40M
Becton Dickinson buys Alverix for $40M
Yahoo/AP
Alverix Technology
devices
Becton Dickinson
M&A
Flag link:
Wearable (Bolus) Injectors: The Next Big Thing In Drug Delivery
Wearable (Bolus) Injectors: The Next Big Thing In Drug Delivery
Seeking Alpha
bolus injectors
devices
drug delivery
Insulet
Becton Dickinson
Unilife
West Pharmaceutical
Flag link:

Pages